Pearl River Capital, LLC Cure Vac N.V. Transaction History

Pearl River Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$33.72 - $48.22 $140,713 - $201,222	-4,173 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$49.26 - $74.5 $205,561 - $310,888	4,173 New	4,173 $228,000
Q2 2021 Aug 13, 2021	SELL	$56.91 - $127.53 $280,566 - $628,722	-4,930 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$79.79 - $126.29 $393,364 - $622,609	4,930 New	4,930 $451,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $484M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.